| Literature DB >> 33797032 |
Yu Wei1,2, Yingsi Zhou1, Yajing Liu1, Wenqin Ying1, Ruiming Lv1, Qimeng Zhao1,2, Haibo Zhou1,3, Erwei Zuo4, Yidi Sun5, Hui Yang6,7, Changyang Zhou8.
Abstract
Entities:
Mesh:
Substances:
Year: 2021 PMID: 33797032 PMCID: PMC8403096 DOI: 10.1007/s13238-021-00824-z
Source DB: PubMed Journal: Protein Cell ISSN: 1674-800X Impact factor: 14.870
Figure 1GOAT detects off-target effects induced by BE3, ABEmax and indiscriminate ssDNA cleavage activity of CRISPR-Cas12a. (A) “Collateral effect” or trans-cleavage in CRISPR-Cas13 and CRISPR-Cas12 systems. DNA replication, transcription, homology-directed repair and R loop structure would lead to the unwinding of double-stranded DNA (dsDNA) to ssDNA. Whether the indiscriminate ssDNA cleavage activity of Cas12a would induce genome-wide off-target effects in mammalian cells needs to be explored. (B) Experimental design of GOAT mediated genome-wide off-target detection. (C) Number of SNVs identified in GFP, BE3, and ABEmax injected groups. (D) Number of indels identified in GFP, BE3, and ABEmax injected groups by WGS. (E) The proportion of G·C to A·T mutations in GPF-, ABEmax-, and BE3-injected groups. Numbers above the columns represent the number of samples. n = 4 for GFP, n = 3 for BE3 and n = 3 for ABEmax groups. All values are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ns, P ≥ 0.05, unpaired t-test
Figure 2On-target editing and off-target effects of LbCas12a and AsCas12a using GOAT. (A) On-target editing efficiency identified by WGS for LbCas12a and AsCas12a groups. (B) Number of SNVs identified in LbCas12a and AsCas12a groups by WGS, where on-target editing was removed from the analysis. (C) Number of indels identified in LbCas12a and AsCas12a groups by WGS. (D) Overlap among SNVs and indels detected by GOAT with predicted off-targets by Cas-OFFinder. (E) Distribution of SNVs in the mouse genome in GFP, LbCas12a-treated and AsCas12a-treated samples. Embryos from inner circle to outer circle were GFP-#1, GFP-#2, GFP-#3, LbCas12a-Dmd-#1, LbCas12a-Dmd-#2, LbCas12a-Dmd-#3, AsCas12a-Dmd-#1, AsCas12a-Dmd-#2 and AsCas12a-Dmd-#3. (F) The distribution of off-target SNVs in the transcribed and un-transcribed regions. P values were calculated by Chi-square test on the number of SNVs in transcribed and un-transcribed regions of each group. (G) Correlation between the target DNA dosage and the presence of cleaved ssDNA. n = 4 twins for GFP, n = 6 twins for LbCas12a and n = 6 twins for AsCas12a groups; numbers above the columns represent the number of samples. All values are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ns, P ≥ 0.05, unpaired t-test. Note that samples of the GFP group are also used in Fig. 1